Risk factors and prognostic factors for inflammatory breast cancer with bone metastasis: A population-based study
Abstract Background: Inflammatory breast cancer (IBC) is a rare type of breast cancer with poor prognosis. IBC patients with bone metastasis (BM) often suffer from many complications. This study was to identify risk factors with strong capability of predicting high BM risk for IBC patients and find prognostic factors of IBC patientsMethods: The Surveillance, Epidemiology and End Results (SEER) database was used to collect the clinicopathological and survival information of IBC patients. 966 IBC patients diagnosed between 2010 and 2015 were to study the risk factors for developing BM by using Multivariable logistic regression. 194 and 176 patients were to analyze independent prognostic factors for overall survival (OS) and cancer specific survival (CSS) of IBC patients with BM by performing Cox proportional hazard model.Results: Of the 966 IBC patients, 194 (20.1%) patients were with BM. IBC patients of unmarried, double breast tumor, N1 stage, N3 stage, and liver metastases had higher risk of BM, while those of uninsured status and triple negative breast cancer (TNBC) were less likely to have BM. The survival analysis showed that TNBC subtype and liver metastases were independently significantly associated with poorer OS and CSS of BM patients, while chemotherapy could serve as an independent prognostic factor for better OS and CSS of BM patients.Conclusions: The risk factors for developing BM could provide potential guidelines for screening BM in IBC patients. The independent prognostic factors for survival outcome of IBC patients with BM could help doctors precisely treat those patients.